Johns Hopkins Wilmer Eye Institute’s 3rd Annual Retinal Festival 2022
Johns Hopkins Wilmer Eye Institute’s 3rd Annual Retinal Festival 2022
Include: 9 videos + 21 pdfs, size: 8.03 GB
The Third Annual Retina Festival is an “all-star” line-up of more than 50 faculty members from around the world participating in a Continuing Medical Education event from the Wilmer Eye Institute of the Johns Hopkins University School of Medicine. The program will provide the latest updates from clinical trials and other evidence in the peer-reviewed medical literature that are relevant to the prevention and management of retinal diseases around the world.
Topics include the latest, clinically relevant outcomes from clinical trials on age-related macular degeneration, vitreomacular interface abnormalities, hereditary retinal degenerations, diabetic retinopathy, retinal vein occlusions, and the latest in retinal surgery, including live retina surgery demonstrations. In addition to presentations from world experts, 4 panels of experts throughout the day will highlight discussions on applying clinical trial results to day-to-day clinical practice. The course should be of interest to comprehensive ophthalmologists, retina specialists both expert and in training, as well as vision scientists who want an update on the latest clinically relevant topics in retina.
WHO SHOULD ATTEND
This activity is intended for ophthalmologists, optometrists, and ophthalmic allied health professionals.
- Recognize the role of anti-angiogenic treatments for eyes with choroidal neovascularization from age-related macular degeneration or diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema.
- Evaluate recent clinical studies evaluating treatments for hereditary retinal degenerations.
- Discuss the role of imaging in the management of vitreomacular interface abnormalities.
- Review the current and emerging therapeutic approaches for surgical retinal diseases.
- Summarize the evidence of surgical and medical treatments for intraocular tumors.
- Determine which patients are appropriate for biologic treatments of posterior uveitis.
The Johns Hopkins Wilmer Eye Institute’s 3rd Annual Retinal Festival (2022) was best for ophthalmologists, retina specialists, fellows, residents, and vision researchers who wanted a fast-paced, evidence-based update on retinal disease management, with insights from global leaders.
👩⚕️ Who Should Attend
- Retina specialists and ophthalmologists managing patients with macular degeneration, diabetic retinopathy, retinal vein occlusion, and other retinal disorders
- Residents and fellows in ophthalmology seeking exposure to high-level case discussions and clinical trial updates
- Vision scientists and researchers interested in translational applications of new therapies
- Allied eye care professionals supporting retinal disease management in clinical practice
📚 What You’d Learn
The 2022 festival featured an “all-star” faculty lineup of more than 50 experts worldwide. Key highlights included:
- Latest updates from clinical trials and peer-reviewed literature relevant to retinal care
- Practical strategies for applying new therapies and imaging technologies in patient management
- Case-based discussions bridging research findings and real-world practice
- Networking opportunities with Johns Hopkins faculty and international retina leaders
Topics:
Saturday, December 3, 2022
- 7:30AM – 7:45AM Welcome and Conference Goals Neil Bressler, MD
- 7:30AM – 7:40AM Zoom Webinar Link
- 7:35AM – 7:45AM Lessons Learned in Retina Research: From Residency to Retirement Paul Sternberg, MD
- 7:45AM – 7:55AM Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management Hendrik P Scholl, MD
- 7:45AM – 8:45AM Moderator: Age-related Macular Degeneration – Geographic Atrophy and Their Masquerades Sandrine Zweifel, MD
- 7:45AM – 8:45AM Moderator: Age-related Macular Degeneration – Geographic Atrophy and Their Masquerades Hendrik P Scholl, MD
- 7:55AM – 8:05AM RPE Transplantation Human Subjects Research Amir H Kashani, MD, PhD
- 8:05AM – 8:15AM Interpreting Geographic Atrophy Progression in Clinical Trials Maureen G Maguire, PhD
- 8:15AM – 8:25AM Clinical Relevance of Recent Geographic Atrophy Clinical Trials Sandrine Zweifel, MD
- 8:45AM – 10:30AM Moderator: Age-related Macular Degeneration – Choroidal Neovascularization J. Fernando Arevalo, MD, PhD
- 8:45AM – 10:30AM Moderator: Age-related Macular Degeneration – Choroidal Neovascularization Cindy X Cai, MD
- 8:45AM – 8:55AM Role of Fluorescein, ICG, and OCT Angiography in Neovascular AMD Voraporn Chaikitmongkol, MD
- 8:55AM – 9:05AM Updates on Gene Therapy to Deliver Anti-VEGF Proteins for Retinal and Choroidal Vascular Diseases: Potential Benefits and Risks Peter A Campochiaro, MD
- 9:05AM – 9:15AM Recent Clinical Trials in Uveitis for the Retina Specialist Douglas A Jabs, MD, MBA
- 9:15AM – 9:25AM Potential Advantages and Disadvantages of Slow Release Devices for Neovascular AMD Dante Pieramici, MD
- 9:25AM – 9:35AM Potential Advantages and Disadvantages of Slow Release Devices for Neovascular AMD Gemmy Cheung, MD
- 10:30AM – 10:40AM Epidemic of Pathologic Myopia Caroline Klaver, MD, PhD
- 10:30AM – 11:15AM Moderator: Pathologic Myopia: Classification of Common Retinal Diseases Adam S Wenick, MD, PhD
- 10:30AM – 11:15AM Moderator: Pathologic Myopia: Classification of Common Retinal Diseases Kyoko Ohno-Matsui, MD
- 10:40AM – 10:50AM Surgical Management of Epiretinal Membranes, Vitreomacular Traction, Macular Holes or Schisis in Pathologic Myopia Taiji Sakamoto, MD, PhD
- 10:50AM – 11:00AM Current Classification of Pathologic Myopia Kyoko Ohno-Matsui, MD
- 11:15AM – 11:25AM Choroidal Melanoma Management in 2023 Carol L Shields, MD
- 11:15AM – 12:45PM Moderator: Intraocular Tumors Carol L Shields, MD
- 11:15AM – 12:45PM Moderator: Intraocular Tumors David H Abramson, MD
- 11:25AM – 11:35AM Recent Advances in Management of Retinoblastoma David H Abramson, MD
- 12:45PM – 1:45PM Moderator: Surgical Innovations in Retina Stanislao Rizzo, MD
- 12:45PM – 1:45PM Moderator: Surgical Innovations in Retina Narine Viruni, MD
- 12:45PM – 12:55PM Updates on Voretigene NeparvovecRZYL and Other Agents for Retinal Degenerations William F Mieler, MD
- 12:55PM – 1:05PM 3D Monitors for Retina Surgery Stanislao Rizzo, MD
- 1:05PM – 1:15PM Gene Therapy in Retinal Diseases in 2022 Jacque Duncan, MD
- 1:15PM – 1:25PM Monitoring ROP in 2022 J Peter P Campbell, MD
- 1:45PM – 1:55PM Choosing Agents for Macular Edema from Retina Vein Occlusions Sobha Sivaprasad, MD
- 1:45PM – 3:00PM Moderator: Retinal Vascular Diseases Adrienne Scott, MD
- 1:45PM – 3:00PM Moderator: Retinal Vascular Diseases Sobha Sivaprasad, MD
- 1:55PM – 2:05PM Biosimilars for Retinal Disease Peter K Kaiser, MD
- 2:05PM – 2:15PM Current Management of Sickle Cell Retinopathy Adrienne Scott, MD
- 3:00PM – 3:45PM Moderator: Diabetic Retinopathy Susan Bressler, MD
- 3:00PM – 3:45PM Moderator: Diabetic Retinopathy Jun Kong, MD, PhD
- 3:00PM – 3:10PM Step Therapy for DME: Protocol AC Results Chirag Jhaveri, MD
- 3:10PM – 3:20PM From Airlie House to ETDRS to DRCR Retina Network in 2022: Imaging NPDR for Risk Factors to Develop PDR Jennifer Sun, MD, MPH
- 3:20PM – 3:30PM Management of Moderate to Severe NPDR: Results from Protocol W Raj Maturi, MD
- 3:45PM – 3:55PM Home Monitoring in AMD or DR: OCT, Visual Acuity or Both Anat Loewenstein, MD
- 3:45PM – 5:25PM Moderator: Other Hot Topics in Retina Mira Sachdeva, MD, PhD
- 3:45PM – 5:25PM Moderator: Other Hot Topics in Retina T. Y. Alvin Liu, MD
- 3:45PM – 5:25PM Moderator: Other Hot Topics in Retina Kapil Mishra, MD
- 3:55PM – 4:05PM Artificial Intelligence in Retina Aaron Lee, MD
- 4:05PM – 4:15PM Diversity, Inclusiveness and Equity in Retina Judy E Kim, MD
- 4:15PM – 4:35PM Faricimab and Other New Anti-VEGF Agents for Neovascular AMD Susan Bressler, MD
- 4:55PM – 5:25PM Summary and Closing Remarks J. Fernando Arevalo, MD, PhD
Related products
